title: Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
abstract: Genetic changes underlying the progression of human prostate cancer are incompletely understood. Recently, an experimental model system that resembles human prostate cancer progression was developed based on the serial passage of an androgen-responsive, non-tumorigenic LNCaP prostate cancer cell line into athymic castrated mice. Six different sublines, derived after one, two or three rounds of in vivo passage, sequentially acquired androgen independence and tumorigenicity as well as metastatic capacity. Here, we used comparative genomic hybridization (CGH) and locus-specific fluorescence in situ hybridization (FISH) analysis to search for genetic changes that may underlie the phenotypic progression events in this model system. Six genetic aberrations were seen by CGH in the parental LNCaP cell line. The derivative sublines shared virtually all these changes, indicating a common clonal origin, but also contained 3-7 additional genetic changes. Gain of the 13q12-q13 chromosomal region as well as losses of 4, 6q24-qter, 20p and 21q were associated with androgen independence and tumorigenicity with additional changes correlating with metastasis. In conclusion, an accumulation of genetic changes correlates with tumour progression in this experimental in vivo model of prostate cancer progression. It is possible that the specific chromosomal aberrations involved in this model system may provide clues to the location of genes involved in human prostate cancer progression and metastasis.
authors.affiliation: Laboratory of Cancer Genetics, Tampere University Hospital, Finland.
authors.forename: E R
authors.initials: ER
authors.lastname: Hyytinen
authors.forename: G N
authors.initials: GN
authors.lastname: Thalmann
authors.forename: H E
authors.initials: HE
authors.lastname: Zhau
authors.forename: R
authors.initials: R
authors.lastname: Karhu
authors.forename: O P
authors.initials: OP
authors.lastname: Kallioniemi
authors.forename: L W
authors.initials: LW
authors.lastname: Chung
authors.forename: T
authors.initials: T
authors.lastname: Visakorpi
mesh_terms: D000728:Androgens / Q000502:physiology; D000818:Animals; D002455:Cell Division; D002869:Chromosome Aberrations / Q000473:pathology; D002872:Chromosome Deletion; D025063:Chromosome Disorders; D002874:Chromosome Mapping; D002878:Chromosomes, Human, Pair 1; D002893:Chromosomes, Human, Pair 3; D002896:Chromosomes, Human, Pair 6; D002999:Clone Cells; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology; D014183:Transplantation, Heterologous
chemical_list: D000728:Androgens